{"id":163591,"date":"2018-08-22T09:30:00","date_gmt":"2018-08-22T09:30:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=163591"},"modified":"2018-08-22T09:30:00","modified_gmt":"2018-08-22T09:30:00","slug":"inventia-revolutionara-care-l-a-transformat-pe-un-tanar-din-marea-britanie-intr-unul-dintre-cei-mai-bogati-barbati-din-tara","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=163591","title":{"rendered":"Inven\u0163ia revolu\u0163ionar\u0103 care l-a transformat pe un t\u00e2n\u0103r din Marea Britanie \u00eentr-unul dintre cei mai boga\u0163i b\u0103rba\u0163i din \u0163ar\u0103"},"content":{"rendered":"<div>\nUn t\u00e2n\u0103r din Marea Britanie a devenit peste noapte unul dintre cei mai boga\u0163i b\u0103rba\u0163i din \u0163ar\u0103 dup\u0103 ce compania de biotehnologie Ziylo, pe care acesta a dezvoltat-o al\u0103turi de unul dintre profesorii s\u0103i din facultate, a fost achizi\u0163ionat\u0103 cu peste 620 de milioane de lire sterline de Novo Nordisk, un gigant la nivel global din domeniu s\u0103n\u0103t\u0103\u0163ii.&nbsp;<\/div>\n<p>\nHarry Destercroix este absolvent al Universit\u0103\u0163ii Bristol din Marea Britanie \u015fi de\u0163ine o diplom\u0103 de doctorat \u00een chimie. Al\u0103turi de Anthony Davis, care i-a fost profesor, a dezvoltat, \u00een timpul facult\u0103\u0163ii, o companie de biotehnologie, Ziylo. \u00cempreun\u0103 cu o echip\u0103 de cercet\u0103tori, cei doi au dezvoltat tratamente care ar putea s\u0103 ajute cei peste 380 de milioane de oameni bolnavi de diabet la nivel mondial, din care patru milioane doar \u00een Marea Britanie.<\/p>\n<p>\nCercet\u00e2nd cazurilor persoanelor bolnave de diabet, Ziylo a dezvoltat o tehnologie care ar putea ajuta la dezvoltarea unui tip de insulin\u0103 care ar putea s\u0103 reac\u0163ioneze \u015fi s\u0103 se adapteze la nivelurile de glucoz\u0103 din s\u00e2nge. Acest lucru ajut\u0103 la eliminarea riscului sc\u0103derii nivelului de zah\u0103r din s\u00e2nge, cunoscut sub numele de hipoglicemie, \u015fi ofer\u0103 diabeticilor un control mai bun asupra bolii.<\/p>\n<p>\nCercet\u0103torii \u015ftiin\u0163ifici din cadrul \u015fcolii de chimie a universit\u0103\u0163ii au \u00eenceput s\u0103 lucreze la aceast\u0103 problem\u0103 cu ani \u00een urm\u0103, \u00eenainte ca Ziylo s\u0103 fie \u00eenfiin\u0163at\u0103 \u00een anul 2014. Dup\u0103 un studiu de 20 de ani, profesorul Davis a reu\u015fit s\u0103 proiecteze un nou tip de molecule sintetice care, \u00eembinate cu cele naturale, &#8220;ar putea constitui o nou\u0103 abordare a biodesignului. Aceste molecule unice au fost inspirate de natur\u0103 \u015fi lucreaz\u0103 \u00een acela\u015fi mod ca \u015fi receptorii naturali de glucoz\u0103\u201d, explic\u0103 Davis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un t\u00e2n\u0103r din Marea Britanie a devenit peste noapte unul dintre cei mai boga\u0163i b\u0103rba\u0163i din \u0163ar\u0103 dup\u0103 ce compania de biotehnologie Ziylo, pe care acesta a dezvoltat-o al\u0103turi de unul dintre profesorii s\u0103i din facultate, a fost achizi\u0163ionat\u0103 cu peste 620 de milioane de lire sterline de Novo Nordisk, un gigant la nivel global [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[10254,170,13243,12946,279,33457,16273,31737,272,15646,7442,15493,15797,28288,10358,30016,7251,30006,85,16545,205,19047,7960,8867],"class_list":["post-163591","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-absolventi","tag-achizitie","tag-ajutor","tag-barbati","tag-bogati","tag-cadre-didactice","tag-cercetatori","tag-chimie","tag-companie","tag-detinere","tag-dezvoltare","tag-diabet","tag-diploma","tag-doctorat","tag-facultate","tag-gigant","tag-marea-britanie","tag-molecule","tag-noapte","tag-profesor","tag-sanatate","tag-sange","tag-tanar","tag-universitate"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/163591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=163591"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/163591\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=163591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=163591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=163591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}